We report the case of a patient with PsA whose treatment with the anti-TNF-α agent, etanercept, resulted not only in improvement of his psoriasis and inflammatory arthritis but also in recurrent hypoglycemia and ultimately near normalization of his HbA1c off of all traditional therapy for T2DM. The gene discussed is TNF; the disease is type 2 diabetes mellitus.